Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1992 Jul;90(1):165–173. doi: 10.1172/JCI115832

Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex.

R L Rubin 1, S A Bell 1, R W Burlingame 1
PMCID: PMC443077  PMID: 1378852

Abstract

IgG reactivity with the (H2A-H2B)-DNA complex, a subunit of the nucleosome, has been detected in many patients with lupus induced by procainamide and quinidine, but the similarity among the epitopes targeted by these antibodies in this heterogeneous patient group as well as the prevalence of this specificity in lupus induced by other drugs is unknown. Studies with histone-DNA complexes formed by sequential addition on a solid phase demonstrated that complexes containing single histones had negligible antigenicity, indicating that DNA stabilizes a protein epitope in the H2A-H2B dimer or that the complete epitope is generated by a surface feature involving H2A-H2B and DNA. F(ab')2 isolated from a patient with procainamide-induced lupus blocked greater than 90% of the anti-[(H2A-H2B)-DNA] reactivity in six of six sera from patients with lupus induced by procainamide, four of four quinidine-induced patients and in sera from patients with lupus induced by acebutolol, penicillamine, and isoniazid, but not methyldopa or auto-antibodies to the component macromolecules. Fab fragments purified from the IgG of two quinidine-induced lupus patients and patients with isoniazid- and procainamide-induced lupus retained 39% +/- 8% of their original IgG reactivity compared to 34 +/- 28% of the original anti-tetanus toxoid activity of Fab fragments in two of the same sera and two normal sera. These results indicate that anti-[(H2A-H2B)-DNA] does not require divalent antigen-antibody complexes for stability, and that the complete epitope is created by the monomeric, trimolecular histone-DNA complex. We conclude that despite their pharmacologic and chemical heterogeneity, many lupus-inducing drugs elicit near identical autoantibodies.

Full text

PDF
165

Images in this article

170Image
on p.170

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arents G., Burlingame R. W., Wang B. C., Love W. E., Moudrianakis E. N. The nucleosomal core histone octamer at 3.1 A resolution: a tripartite protein assembly and a left-handed superhelix. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10148–10152. doi: 10.1073/pnas.88.22.10148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Budinsky R. A., Roberts S. M., Coats E. A., Adams L., Hess E. V. The formation of procainamide hydroxylamine by rat and human liver microsomes. Drug Metab Dispos. 1987 Jan-Feb;15(1):37–43. [PubMed] [Google Scholar]
  3. Burlingame R. W., Love W. E., Wang B. C., Hamlin R., Nguyen H. X., Moudrianakis E. N. Crystallographic structure of the octameric histone core of the nucleosome at a resolution of 3.3 A. Science. 1985 May 3;228(4699):546–553. doi: 10.1126/science.3983639. [DOI] [PubMed] [Google Scholar]
  4. Burlingame R. W., Rubin R. L. Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin. J Clin Invest. 1991 Aug;88(2):680–690. doi: 10.1172/JCI115353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Burlingame R. W., Rubin R. L. Subnucleosome structures as substrates in enzyme-linked immunosorbent assays. J Immunol Methods. 1990 Dec 5;134(2):187–199. doi: 10.1016/0022-1759(90)90380-e. [DOI] [PubMed] [Google Scholar]
  6. Böhm E. L., Strickland W. N., Strickland M., Thwaits B. H., van der Westhuizen D. R., von Holt C. Purification of the five main calf thymus histone fractions by gel exclusion chromatography. FEBS Lett. 1973 Aug 15;34(2):217–221. doi: 10.1016/0014-5793(73)80797-5. [DOI] [PubMed] [Google Scholar]
  7. Cohen M. G., Kevat S., Prowse M. V., Ahern M. J. Two distinct quinidine-induced rheumatic syndromes. Ann Intern Med. 1988 Mar;108(3):369–371. doi: 10.7326/0003-4819-108-3-369. [DOI] [PubMed] [Google Scholar]
  8. Craft J. E., Radding J. A., Harding M. W., Bernstein R. M., Hardin J. A. Autoantigenic histone epitopes: a comparison between procainamide- and hydralazine-induced lupus. Arthritis Rheum. 1987 Jun;30(6):689–694. doi: 10.1002/art.1780300612. [DOI] [PubMed] [Google Scholar]
  9. Daban J. R., Cantor C. R. Structural and kinetic study of the self-assembly of nucleosome core particles. J Mol Biol. 1982 Apr 25;156(4):749–769. doi: 10.1016/0022-2836(82)90140-1. [DOI] [PubMed] [Google Scholar]
  10. Enzenauer R. J., West S. G., Rubin R. L. D-penicillamine-induced lupus erythematosus. Arthritis Rheum. 1990 Oct;33(10):1582–1585. doi: 10.1002/art.1780331018. [DOI] [PubMed] [Google Scholar]
  11. Epstein A., Greenberg M., Halbert S., Kramer L., Barland P. The clinical application of an ELISA technique for the detection of antihistone antibodies. J Rheumatol. 1986 Apr;13(2):304–307. [PubMed] [Google Scholar]
  12. Fritzler M. J., Tan E. M. Antibodies to histones in drug-induced and idiopathic lupus erythematosus. J Clin Invest. 1978 Sep;62(3):560–567. doi: 10.1172/JCI109161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gohill J., Fritzler M. J. Antibodies in procainamide-induced and systemic lupus erythematosus bind the C-terminus of histone 1 (H1). Mol Immunol. 1987 Mar;24(3):275–285. doi: 10.1016/0161-5890(87)90146-5. [DOI] [PubMed] [Google Scholar]
  14. Goodnow C. C., Crosbie J., Jorgensen H., Brink R. A., Basten A. Induction of self-tolerance in mature peripheral B lymphocytes. Nature. 1989 Nov 23;342(6248):385–391. doi: 10.1038/342385a0. [DOI] [PubMed] [Google Scholar]
  15. Grossman L., Barland P. Histone reactivity of drug-induced antinuclear antibodies. A comparison of symptomatic and asymptomatic patients. Arthritis Rheum. 1981 Jul;24(7):927–931. doi: 10.1002/art.1780240710. [DOI] [PubMed] [Google Scholar]
  16. Harmon C. E., Portanova J. P. Drug-induced lupus: clinical and serological studies. Clin Rheum Dis. 1982 Apr;8(1):121–135. [PubMed] [Google Scholar]
  17. Hobbs R. N., Lea D. J., Phua K. K., Johnson P. M. Binding of isolated rheumatoid factors to histone proteins and basic polycations. Ann Rheum Dis. 1983 Aug;42(4):435–438. doi: 10.1136/ard.42.4.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Klajman A., Farkas R., Gold E., Ben-Efraim S. Procainamide-induced antibodies to nucleoprotein, denatured and native DNA in human subjects. Clin Immunol Immunopathol. 1975 Mar;3(4):525–530. doi: 10.1016/0090-1229(75)90077-x. [DOI] [PubMed] [Google Scholar]
  19. Klajman A., Kafri B., Shohat T., Drucker I., Moalem T., Jaretzky A. The prevalence of antibodies to histones induced by procainamide in old people, in cancer patients, and in rheumatoid-like disease. Clin Immunol Immunopathol. 1983 Apr;27(1):1–8. doi: 10.1016/0090-1229(83)90050-8. [DOI] [PubMed] [Google Scholar]
  20. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  21. Lahita R., Kluger J., Drayer D. E., Koffler D., Reidenberg M. M. Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide. N Engl J Med. 1979 Dec 20;301(25):1382–1385. doi: 10.1056/NEJM197912203012506. [DOI] [PubMed] [Google Scholar]
  22. Lee S. L., CHase P. H. Drug-induced systemic lupus erythematosus: a critical review. Semin Arthritis Rheum. 1975 Aug;5(1):83–103. doi: 10.1016/0049-0172(75)90024-4. [DOI] [PubMed] [Google Scholar]
  23. Mencke A. J., Rill R. L. Circular dichroism and thermal denaturation studies of subnucleosomes and their relationships to nucleosome structure. Biochemistry. 1982 Aug 31;21(18):4362–4370. doi: 10.1021/bi00261a027. [DOI] [PubMed] [Google Scholar]
  24. Nelson D. A., Mencke A. J., Chambers S. A., Oosterhof D. K., Rill R. L. Subnucleosomes and their relationships to the arrangement of histone binding sites along nucleosome deoxyribonucleic acid. Biochemistry. 1982 Aug 31;21(18):4350–4362. doi: 10.1021/bi00261a026. [DOI] [PubMed] [Google Scholar]
  25. Nordstrom D. M., West S. G., Rubin R. L. Methyldopa-induced systemic lupus erythematosus. Arthritis Rheum. 1989 Feb;32(2):205–208. doi: 10.1002/anr.1780320214. [DOI] [PubMed] [Google Scholar]
  26. Nossal G. J., Karvelas M. Soluble antigen abrogates the appearance of anti-protein IgG1-forming cell precursors during primary immunization. Proc Natl Acad Sci U S A. 1990 Feb;87(4):1615–1619. doi: 10.1073/pnas.87.4.1615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Parker C. W. Hapten immunology and allergic reactions in humans. Arthritis Rheum. 1981 Aug;24(8):1024–1036. doi: 10.1002/art.1780240808. [DOI] [PubMed] [Google Scholar]
  28. Portanova J. P., Arndt R. E., Tan E. M., Kotzin B. L. Anti-histone antibodies in idiopathic and drug-induced lupus recognize distinct intrahistone regions. J Immunol. 1987 Jan 15;138(2):446–451. [PubMed] [Google Scholar]
  29. Portanova J. P., Rubin R. L., Joslin F. G., Agnello V. D., Tan E. M. Reactivity of anti-histone antibodies induced by procainamide and hydralazine. Clin Immunol Immunopathol. 1982 Oct;25(1):67–79. doi: 10.1016/0090-1229(82)90166-0. [DOI] [PubMed] [Google Scholar]
  30. Rechsteiner M. Ubiquitin-mediated pathways for intracellular proteolysis. Annu Rev Cell Biol. 1987;3:1–30. doi: 10.1146/annurev.cb.03.110187.000245. [DOI] [PubMed] [Google Scholar]
  31. Richmond T. J., Finch J. T., Rushton B., Rhodes D., Klug A. Structure of the nucleosome core particle at 7 A resolution. Nature. 1984 Oct 11;311(5986):532–537. doi: 10.1038/311532a0. [DOI] [PubMed] [Google Scholar]
  32. Roberts S. M., Adams L. E., Donovan-Brand R., Budinsky R., Skoulis N. P., Zimmer H., Hess E. V. Procainamide hydroxylamine lymphocyte toxicity--I. Evidence for participation by hemoglobin. Int J Immunopharmacol. 1989;11(4):419–427. doi: 10.1016/0192-0561(89)90089-1. [DOI] [PubMed] [Google Scholar]
  33. Rubin R. L., Curnutte J. T. Metabolism of procainamide to the cytotoxic hydroxylamine by neutrophils activated in vitro. J Clin Invest. 1989 Apr;83(4):1336–1343. doi: 10.1172/JCI114020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Rubin R. L., McNally E. M., Nusinow S. R., Robinson C. A., Tan E. M. IgG antibodies to the histone complex H2A-H2B characterize procainamide-induced lupus. Clin Immunol Immunopathol. 1985 Jul;36(1):49–59. doi: 10.1016/0090-1229(85)90038-8. [DOI] [PubMed] [Google Scholar]
  35. Rubin R. L., Nusinow S. R., Johnson A. D., Rubenson D. S., Curd J. G., Tan E. M. Serologic changes during induction of lupus-like disease by procainamide. Am J Med. 1986 May;80(5):999–1002. doi: 10.1016/0002-9343(86)90653-4. [DOI] [PubMed] [Google Scholar]
  36. Rubin R. L., Reimer G., McNally E. M., Nusinow S. R., Searles R. P., Tan E. M. Procainamide elicits a selective autoantibody immune response. Clin Exp Immunol. 1986 Jan;63(1):58–67. [PMC free article] [PubMed] [Google Scholar]
  37. Rubin R. L., Tang F. L., Chan E. K., Pollard K. M., Tsay G., Tan E. M. IgG subclasses of autoantibodies in systemic lupus erythematosus, Sjogren's syndrome, and drug-induced autoimmunity. J Immunol. 1986 Oct 15;137(8):2528–2534. [PubMed] [Google Scholar]
  38. Rubin R. L., Uetrecht J. P., Jones J. E. Cytotoxicity of oxidative metabolites of procainamide. J Pharmacol Exp Ther. 1987 Sep;242(3):833–841. [PubMed] [Google Scholar]
  39. Tan E. M. Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol. 1982;33:167–240. doi: 10.1016/s0065-2776(08)60836-6. [DOI] [PubMed] [Google Scholar]
  40. Totoritis M. C., Tan E. M., McNally E. M., Rubin R. L. Association of antibody to histone complex H2A-H2B with symptomatic procainamide-induced lupus. N Engl J Med. 1988 Jun 2;318(22):1431–1436. doi: 10.1056/NEJM198806023182204. [DOI] [PubMed] [Google Scholar]
  41. Uetrecht J. P., Sweetman B. J., Woosley R. L., Oates J. A. Metabolism of procainamide to a hydroxylamine by rat and human hepatic microsomes. Drug Metab Dispos. 1984 Jan-Feb;12(1):77–81. [PubMed] [Google Scholar]
  42. Weisbart R. H., Yee W. S., Colburn K. K., Whang S. H., Heng M. K., Boucek R. J. Antiguanosine antibodies: a new marker for procainamide-induced systemic lupus erythematosus. Ann Intern Med. 1986 Mar;104(3):310–313. doi: 10.7326/0003-4819-104-3-310. [DOI] [PubMed] [Google Scholar]
  43. West S. G., McMahon M., Portanova J. P. Quinidine-induced lupus erythematosus. Ann Intern Med. 1984 Jun;100(6):840–842. doi: 10.7326/0003-4819-100-6-840. [DOI] [PubMed] [Google Scholar]
  44. Wheeler J. F., Adams L. E., Mongey A. B., Roberts S. M., Heineman W. R., Hess E. V. Determination of metabolically derived nitroprocainamide in the urine of procainamide-dosed humans and rats by liquid chromatography with electrochemical detection. Drug Metab Dispos. 1991 May-Jun;19(3):691–695. [PubMed] [Google Scholar]
  45. Wray W., Boulikas T., Wray V. P., Hancock R. Silver staining of proteins in polyacrylamide gels. Anal Biochem. 1981 Nov 15;118(1):197–203. doi: 10.1016/0003-2697(81)90179-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES